AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Oxagen, Cerylid Partner For Genetic Study Of Endometriosis.(Oxagen Ltd. and Cerylid Biosciences Ltd.)(Brief Article)
2001 OCT 11 - (NewsRx.com & NewsRx.net) --
Oxagen Ltd., a privately held genomics company based in Abingdon, U.K., and Cerylid Biosciences Ltd., a genomics-driven drug discovery company based in Melbourne, Australia, have agreed to collaborate to investigate the genetics of endometriosis. Oxagen and Cerylid are already conducting separate extensive, family-based genetic studies on endometriosis with leading academic groups.
The new collaborative research program is believed to be the world's largest genetic study in this debilitating disease, and will include more than 2,000 families affected with endometriosis. The goal of the collaboration is to discover genes and polymorphisms that influence susceptibility to endometriosis, and deliver targets from which new diagnostics and treatments for the disease can be developed.
Endometriosis is a disease characterized by severe pelvic pain and fertility ...
- Cerylid Biosciences and Anadys Pharmaceuticals Announce Anti-Infective Drug...
- Press release article from: Business Wire June 6, 2002 700+ words
...Anadys' uHTS-ATLAS(TM) Technology Cerylid Biosciences Limited (Cerylid) and Anadys Pharmaceuticals...visit www.anadyspharma.com. About Cerylid Biosciences Limited Cerylid Biosciences Limited is a Melbourne, Australia...
- Cerylid's blood-thinner superior to aspirin?(product development by Cerylid...
- Newspaper article from: Pharma Marketletter May 2, 2005 700+ words
...version of the initial intravenous form is being developed for oral administration. Australian biotechnology group Cerylid Biosciences owns the commercial rights to the agent, a phosphatidyl 3-kinase inhibitor which targets blood clots without...
- Charter Hospital Closings May Signal Bigger Problems Ahead, Reports Mental...
- Press release article from: PR Newswire February 14, 2000 700+ words
...reports this week's issue of Mental Health Weekly. The stark numbers include 33 hospital...Karen Keiser-Jenkins told Mental Health Weekly last week. Keiser-Jenkins says the...Newswire. For more information on Mental Health Weekly, click on "Newsletters" to receive...
- Problems With Managed Mental Health Program Hold Lesson For Other States,...
- Press release article from: PR Newswire February 15, 1999 700+ words
...contract in state history, this week's issue of Mental Health Weekly reports. Earlier this month, the Montana legislature...Magellan. Center executive director Paul Meyer told Mental Health Weekly that in the last six months, Magellan has denied $500...
- News You Can Use.(Rachel's Environmental and Health Weekly, periodical)(Brief...
- Magazine article from: E Franz, Damon January 1, 2000 700+ words
...weekly publication of the Environmental Research Foundation (ERF). Much like its namesake, Rachel's Environment and Health Weekly sounds the warning about hazardous substances and technologies that threaten human and that environmental health. Rachel...
- Wine slightly better than beer for cardiac health.(Weekly Marketplace)(Brief...
- Magazine article from: Modern Brewery Age February 14, 2005 700+ words
A recent article in the Journal of Thrombosis and Haemostasis determined that drinkers of wine benefit from its cardioprotective effects, more so than those who drink beer or other spirits, and wine drinkers may also live longer. The article is part of a series of papers published in an open forum
- AUSTRALIAN DRUG CO RECEIVES $US5MLN INJECTION FROM JBWERE.
- News wire article from: AsiaPulse News August 24, 2001 700+ words
...MediaNet International-AsiaNet - Cerylid Biosciences and JBWere today announced the completion...Australian drug discovery company, Cerylid Biosciences Limited. To date, the JBWere Private...capital raised to $11 million. Cerylid Biosciences is a genomics-driven drug discovery...
- OXAGEN AND CERYLID ENTER PARTNERSHIP TO STUDY ENDOMETRIOSIS.
- News wire article from: AsiaPulse News August 30, 2001 700+ words
...company based in Abingdon, UK, and Cerylid Biosciences Limited, a genomics-driven drug...oxagen.co.uk About Cerylid Cerylid Biosciences is a genomics-driven drug discovery...activities. For further information on Cerylid Biosciences visit www.cerylid.com.au For...